Prosecution Insights
Last updated: October 25, 2026

Korea Institute Of Ceramic Engineering And Technology

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Analysis

Korea Institute Of Ceramic Engineering And Technology has 7 pending office actions in Chemistry & Materials. The matters are distributed across 7 distinct examiners and 7 distinct art units, indicating a fully dispersed examination structure within the same technical area.

LI, WENHAN is the busiest examiner, with 1 pending matter. No examiner has a larger pending assignment in the supplied data, so docket management should treat each record as a separate prosecution workstream rather than relying on a dominant examiner relationship.

The broad distribution increases the importance of consistent technical terminology, coordinated disclosure positions, and matter-level deadline control. Counsel should compare the substance of the actions for recurring chemistry or materials issues, while preserving arguments tailored to each art-unit assignment.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

7
Total Pending OAs
4
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (57%)
3
Medium (43%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (43%)
Multi-statute (no §101)4 (57%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LI, WENHAN 1 — —
BRATLAND JR, KENNETH A 1 56.2% +16.3%
BOLDEN, ELIZABETH A 1 85.1% +22.1%
MILLER, CAMERON KENNETH 1 81.6% +0.3%
LAW, NGA LEUNG V 1 56.4% +19.8%
WHITE, ASHLEY TAYLOR 1 23.8% +36.7%
MCCLURE, JOSHUA PATRICK 1 50.5% +9.9%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18103883 HIGH-VOLTAGE ANTIFERROELECTRIC AND MANUFACTURING METHOD THEREOF MILLER, CAMERON KENNETH 190d overdue

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17936657 FUSION PROTEIN OF Z-DOMAIN AND CALSEQUESTRIN, HAVING IMPROVED REACTIVITY, STABILITY, AND ANTIBODY RECOVERY, AND METHOD FOR ISOLATION AND PURIFICATION OF ANTIBODY USING SAME WHITE, ASHLEY TAYLOR 74d overdue
17980287 PLASMA RESISTANT CERAMIC MEMBER AND MANUFACTURING METHOD OF THE SAME LAW, NGA LEUNG V 39d
18918549 REACTIVE OXYGEN SPECIES-RESPONSIVE DRUG DELIVERY PARTICLES, WOUND HEALING METHOD USING REACTIVE OXYGEN SPECIES-RESPONSIVE DRUG DELIVERY PARTICLES AND PHOTOBIOMODULATION, AND DEVICE FOR WOUND HEALING LI, WENHAN —
18816567 METHOD FOR GROWING GALLIUM OXIDE SINGLE CRYSTAL AND APPARATUS FOR GROWING SINGLE CRYSTAL BRATLAND JR, KENNETH A —
18248312 PLASMA-RESISTANT GLASS AND MANUFACTURING METHOD THEREFOR BOLDEN, ELIZABETH A —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17936657 FUSION PROTEIN OF Z-DOMAIN AND CALSEQUESTRIN, HAVING IMPROVED REACTIVITY, STABILITY, AND ANTIBODY RECOVERY, AND METHOD FOR ISOLATION AND PURIFICATION OF ANTIBODY USING SAME WHITE, ASHLEY TAYLOR 74d overdue
17980287 PLASMA RESISTANT CERAMIC MEMBER AND MANUFACTURING METHOD OF THE SAME LAW, NGA LEUNG V 39d
18816567 METHOD FOR GROWING GALLIUM OXIDE SINGLE CRYSTAL AND APPARATUS FOR GROWING SINGLE CRYSTAL BRATLAND JR, KENNETH A —
18248312 PLASMA-RESISTANT GLASS AND MANUFACTURING METHOD THEREFOR BOLDEN, ELIZABETH A —

Top Art Units

Art UnitApps
1614 1
1714 1
1731 1
1700 1
1717 1
1653 1
1727 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18918549 REACTIVE OXYGEN SPECIES-RESPONSIVE DRUG DELIVERY PARTICLES, WOUND HEALING METHOD USING REACTIVE OXYGEN SPECIES-RESPONSIVE DRUG DELIVERY PARTICLES AND PHOTOBIOMODULATION, AND DEVICE FOR WOUND HEALING LI, WENHAN 1614 §102§103 Non-Final OA — Pending Oct 17, 2024
18816567 METHOD FOR GROWING GALLIUM OXIDE SINGLE CRYSTAL AND APPARATUS FOR GROWING SINGLE CRYSTAL BRATLAND JR, KENNETH A 1714 §102§103§112 Non-Final OA — Pending Aug 27, 2024
18248312 PLASMA-RESISTANT GLASS AND MANUFACTURING METHOD THEREFOR BOLDEN, ELIZABETH A 1731 §103§112 Non-Final OA — Pending Apr 07, 2023
18103883 HIGH-VOLTAGE ANTIFERROELECTRIC AND MANUFACTURING METHOD THEREOF MILLER, CAMERON KENNETH 1700 §103 Final Rejection 190d overdue Pending Jan 31, 2023
17980287 PLASMA RESISTANT CERAMIC MEMBER AND MANUFACTURING METHOD OF THE SAME LAW, NGA LEUNG V 1717 §103§112 Final Rejection 39d Pending Nov 03, 2022
17936657 FUSION PROTEIN OF Z-DOMAIN AND CALSEQUESTRIN, HAVING IMPROVED REACTIVITY, STABILITY, AND ANTIBODY RECOVERY, AND METHOD FOR ISOLATION AND PURIFICATION OF ANTIBODY USING SAME WHITE, ASHLEY TAYLOR 1653 §103 Non-Final OA 74d overdue Pending Sep 29, 2022
17561523 SILICON-CARBON COMPOSITE NEGATIVE-ELECTRODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERY HAVING IMPROVED ELECTROCHEMICAL PROPERTIES, METHOD FOR PRODUCING THE SAME, AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME MCCLURE, JOSHUA PATRICK 1727 §103 Final Rejection — Pending Dec 23, 2021

Managing Korea Institute Of Ceramic Engineering And Technology's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Korea Institute Of Ceramic Engineering And Technology have?

Korea Institute Of Ceramic Engineering And Technology has 7 pending office actions as of October 2026, spread across 7 art units and 7 examiners.

Which USPTO examiner handles the most Korea Institute Of Ceramic Engineering And Technology applications?

Wenhan Li has the most, with 1 of Korea Institute Of Ceramic Engineering And Technology's pending office actions.

What technology area are Korea Institute Of Ceramic Engineering And Technology's patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month